Nutex Health Inc. NUTX Ratios & Valuation
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 47.5%-3.3pp | 50.8%-4.3pp | 55%+3.7pp | 51.4%+2.6pp | 48.8%+7.9pp | |
| Operating margin | 31.4%-0.1pp | 31.5%-5.1pp | 36.6%+6.5pp | 30.1%-3.5pp | 33.6%+6.4pp | |
| Net margin | 11%+2.9pp | 8.1%-4.2pp | 12.3%+5.2pp | 7.1%-4.7pp | 11.8%+0.9pp | |
| EBITDA margin | 33.8%-0.1pp | 33.8%-4.8pp | 38.7%+6.0pp | 32.7%-4.1pp | 36.8%+5.6pp | |
| Free cash flow margin | 30.6%+2.5pp | 28.1%+10.1pp | 18%+7.5pp | 10.6%-0.6pp | 11.2%+6.8pp | |
| Returns | ||||||
| Return on equity | 35.5%+4.8pp | 30.7%-33.3pp | 63.9%+26.0pp | 37.9%-18.8pp | 56.7%+2.9pp | |
| Return on assets | 11.2%+2.2pp | 9%-8.2pp | 17.2%+8.3pp | 8.9%-3.7pp | 12.6%+2.7pp | |
| Return on invested capital | 45.6%+1.6pp | 44%-26.7pp | 70.7%+22.3pp | 48.3%+3.0pp | 45.3%+14.7pp | |
| Efficiency | ||||||
| Asset turnover | 1×-0.1× | 1.1×-0.3× | 1.4×+0.1× | 1.3×+0.2× | 1.1×+0.2× | |
| Liquidity | ||||||
| Current ratio | 3.1×-0.3× | 3.4×+0.2× | 3.2×+0.8× | 2.4×+0.2× | 2.3×+0.4× | |
| Quick ratio | 3.1×-0.3× | 3.4×+0.2× | 3.2×+0.8× | 2.4×+0.2× | 2.3×+0.4× | |
| Cash ratio | 1.1×0.0× | 1.2×+0.3× | 0.9×+0.4× | 0.5×0.0× | 0.5×+0.2× | |
| Leverage | ||||||
| Debt-to-equity | 1×-0.1× | 1.1×0.0× | 1.1×-0.3× | 1.4×-0.3× | 1.7×-0.8× | |
| Debt-to-assets | 0.4×0.0× | 0.4×0.0× | 0.4×0.0× | 0.4×0.0× | 0.4×-0.1× | |
| Net debt / EBITDA | 0.5×-0.1× | 0.6×+0.1× | 0.5×-0.4× | 0.9×— | —— | |
| Interest coverage | 13.3×+0.9× | 12.4×-3.7× | 16.1×+5.4× | 10.7×+1.0× | 9.7×+3.2× | |
| Valuation | ||||||
| Market capitalization | $1.03B+62.2% | $1.16B+103% | $573.95M-10.4% | $640.73M+151% | $255.7M+48.4% | |
| Enterprise value | $1.16B+32.0% | $1.33B+74.6% | $761.2M-13.6% | $881.38M+74.5% | $505.21M+7.9% | |
| Price / earnings | 10.7×+2.1× | 16.4×+11.7× | 4.8×— | —— | —— | |
| Price / sales | 1.2×+0.2× | 1.3×+0.7× | 0.6×-0.2× | 0.8×+0.4× | 0.4×+0.1× | |
| Price / book | 3×-0.2× | 3.5×+1.7× | 1.8×-0.9× | 2.7×+1.4× | 1.3×0.0× | |
| EV / EBITDA | 3.9×+0.1× | 4.5×+2.5× | 2×-1.4× | 3.4×— | —— | |
| EV / sales | 1.3×-0.1× | 1.5×+0.7× | 0.8×-0.3× | 1.1×+0.3× | 0.8×-0.2× | |
| Free cash flow yield | 26.2%+15.2pp | 21.1%-9.7pp | 30.8%+17.7pp | 13%-14.2pp | 27.3%+15.0pp | |
| Earnings yield | 9.4%-2.3pp | 6.1%-14.9pp | 21%+12.2pp | 8.8%-20.0pp | 28.8%-1.4pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Nutex Health Inc.'s profit margins?
- Nutex Health Inc. (NUTX) runs a 47.5% gross margin and a 31.4% operating margin, with a 11.0% net margin.
- Where do Nutex Health Inc.'s ratios come from?
- Every ratio is computed from Nutex Health Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
